![]() |
市場調查報告書
商品編碼
1700089
2032 年醫療美容設備市場預測:按產品類型、應用、最終用戶和地區進行的全球分析Medical Aesthetic Devices Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球醫療美容設備市場預計在 2025 年達到 177 億美元,到 2032 年將達到 368 億美元,預測期內的複合年成長率為 11%。
醫療美容設備是用於改變體形、治療皮膚問題和改善外觀等美容手術的先進設備。這些設備包括射頻設備、基於能量的設備、雷射系統、微晶換膚設備等等。它們用於疤痕治療、塑身、除毛、活膚等。這些方法廣泛應用於醫院、醫療水療中心和皮膚病診所,可確保美容手術的微創性和高成功率。
《國際醫學資訊學期刊》發表的一項研究顯示,近 60% 的台灣勞工階級每年在整形外科和顯微手術上花費 2,300美國至 6,700 美元。
人口老化加劇
全球老齡人口的不斷增加是醫療美容設備市場的主要推動力。越來越多的老年人尋求治療來解決與老齡化相關的問題,如皺紋、體積減少和皮膚鬆弛。根據世界衛生組織預測,到 2050 年,60 歲以上人口數量將增加一倍,這將刺激抗衰老治療的需求。此外,包括雷射治療和真皮填充劑在內的微創技術的進步滿足了這一人群對快速恢復和自然效果的偏好。這些人口結構的變化確保了持續的需求。
醫療費用高昂
雷射系統和基於能量的設備等先進技術需要大量的前期投資,這限制了中端診所和患者的使用。此外,維護成本和選擇性美容手術缺乏保險覆蓋也加劇了財務挑戰。例如,飛梭雷射治療每次治療的費用超過 1,000 美元,這讓注重價格的消費者望而卻步。這種經濟負擔限制了市場滲透,尤其是在可支配收入較低的地區。
非侵入性手術的擴展
肉毒桿菌注射、超音波治療和冷凍溶脂等非侵入性和微創手術的日益普及代表著巨大的成長機會。這些療程吸引了那些尋求美容但又不想承受手術風險和停機時間的消費者。此外,人工智慧設備和可攜式系統等技術創新正在擴大可訪問性。那些投資於研發輕鬆高效解決方案的公司正在獲得關注,尤其是在年輕人群中。全球範圍內向「午餐治療」和預防性美容治療的轉變進一步放大了這一趨勢,為市場參與者創造了有利可圖的管道。
負面聲譽和虛假訊息
有關失敗程序的負面宣傳和社交媒體上的錯誤訊息威脅著市場的成長。由於不合格的醫生和不合格的設備而導致的併發症的嚴重案例損害了消費者的信心。此外,經過編輯的社群媒體內容所引發的不切實際的期望會導致挫折感並疏遠潛在客戶。監管機構已加強監管,但全球標準仍不一致。
2020年,疫情暫時擾亂了醫美設備市場。供應鏈瓶頸導致設備生產延遲,可支配收入下降抑制了需求。然而,疫情過後,在強勁需求和醫療旅遊復甦的推動下,經濟出現了強勁復甦。此外, LED 面膜和微電流工具等家用美容設備的興起在停工期間也廣受歡迎,形成了混合需求模式。
預計預測期內能源設備領域將實現最大幅度成長。
由於對雷射、超音波和射頻美容療程的需求不斷成長,預計預測期內基於能量的設備部分將佔據最大的市場佔有率。這些設備為緊緻皮膚、減少脂肪、除毛和減少皺紋提供了有效的解決方案,停機時間最短。此外,持續的技術進步正在提高治療效率和患者的治療效果,從而導致診所和醫療水療中心擴大採用該技術。此外,消費者對非侵入性美容手術的認知和接受度不斷提高,進一步增強了該領域的主導地位。
預計預測期內家用領域將以最高的複合年成長率成長。
由於消費者對便利且經濟實惠的美容護理的偏好日益增強,預計家用美容領域將在預測期內實現最高成長率。用於活膚、除毛和抗衰老療法的攜帶式和易於使用的設備的出現正在推動市場擴張。此外,新冠疫情加速了人們向居家美容解決方案的轉變,進一步增加了需求。此外,設備安全性、有效性以及與行動應用程式的連接性的進步正在改善用戶體驗,促進家用美容設備的快速普及。
由於消費者在整容手術上的支出較高且醫療保健基礎設施完善,預計北美將在預測期內佔據最大的市場佔有率。微創和非侵入性治療的日益接受度以及主要市場參與者的存在也在加強區域優勢。此外,技術進步和頻繁的產品推出也促進了市場的擴張。此外,人們的意識不斷增強以及社交媒體的影響力正在推動醫療美容設備的普及,從而鞏固了該公司作為北美行業領先者的地位。
由於可支配收入增加、美容意識增強以及醫療旅遊業擴大,預計亞太地區將在預測期內出現最高的複合年成長率。由於中等收入階層的擴大和美容治療需求的增加,中國、印度和韓國等國家正在經歷顯著的成長。此外,美容技術的進步和可負擔的治療費用正在吸引更大的消費者群體。此外,熟練勞動力的存在和政府的支持政策進一步加速了該地區對醫療美容設備的採用。
According to Stratistics MRC, the Global Medical Aesthetic Devices Market is accounted for $17.7 billion in 2025 and is expected to reach $36.8 billion by 2032 growing at a CAGR of 11% during the forecast period. Medical aesthetic devices are advanced instruments used in cosmetic procedures to alter body shapes, treat skin problems, and enhance looks. These gadgets include radiofrequency equipment, energy-based gadgets, laser systems, and microdermabrasion instruments. They are applied to scar therapy, body shaping, hair removal, and skin rejuvenation. These methods, which are widely used in hospitals, medical spas, and dermatology clinics, guarantee minimally invasive and successful aesthetic procedures.
According to a study published in the International Journal of Medical Informatics, nearly 60% of Taiwan's working class spent between US $2300 to US $6700 on plastic surgery and microsurgery each year.
Increasing aging population
The global rise in the aging population is a key driver for the medical aesthetic devices market, as older individuals increasingly seek treatments to address age-related concerns such as wrinkles, volume loss, and skin laxity. According to the WHO, the population aged 60+ is projected to double by 2050, fueling demand for anti-aging procedures. Furthermore, advancements in minimally invasive technologies, including laser therapies and dermal fillers, cater to this demographic's preference for quick recovery and natural results. This demographic shift ensures sustained demand.
High cost of treatments
Advanced technologies like laser systems and energy-based devices require substantial upfront investments, limiting accessibility for mid-tier clinics and patients. Additionally, maintenance expenses and the lack of insurance coverage for elective aesthetic treatments exacerbate affordability challenges. For example, a single session of fractional laser therapy can cost upwards of $1,000, deterring price-sensitive consumers. This financial burden restricts market penetration, especially in regions with lower disposable incomes.
Expanding non-invasive procedures
The growing popularity of non-invasive and minimally invasive procedures, such as Botox, ultrasound therapy, and cryolipolysis, presents a major growth opportunity. These treatments appeal to consumers seeking aesthetic enhancements without surgical risks or downtime. Moreover, technological innovations like AI-powered devices and portable systems are broadening accessibility. Companies investing in R&D for pain-free, efficient solutions are gaining traction, particularly among younger demographics. The global shift toward "lunchtime procedures" and preventive aesthetics further amplifies this trend, creating a lucrative pipeline for market players.
Negative publicity and misinformation
Negative publicity surrounding botched procedures and misinformation on social media platforms threatens market growth. High-profile cases of complications from unqualified practitioners or substandard devices erode consumer trust. Additionally, unrealistic expectations fueled by edited social media content lead to dissatisfaction, deterring potential clients. Regulatory bodies are intensifying scrutiny, but inconsistent standards globally persist.
The pandemic temporarily disrupted the medical aesthetics market in 2020, as lockdowns forced clinics to close and patients deferred elective procedures. Supply chain bottlenecks delayed device manufacturing, while reduced disposable incomes lowered demand. However, the post-pandemic period saw a robust rebound, driven by pent-up demand and the resurgence of medical tourism. Additionally, the rise of at-home aesthetic devices, such as LED masks and microcurrent tools, gained traction during lockdowns, creating a hybrid demand model.
The energy-based devices segment is expected to be the largest during the forecast period
The energy-based devices segment is expected to account for the largest market share during the forecast period, driven by rising demand for laser, ultrasound, and radiofrequency-based aesthetic treatments. These devices offer effective solutions for skin tightening, fat reduction, hair removal, and wrinkle reduction with minimal downtime. Additionally, continuous technological advancements improve treatment efficiency and patient outcomes, increasing adoption among clinics and medspas. Moreover, growing consumer awareness and acceptance of non-invasive aesthetic procedures further contribute to the segment's dominance.
The home use segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home use segment is predicted to witness the highest growth rate, driven by increasing consumer preference for convenient and cost-effective aesthetic treatments. The availability of portable and easy-to-use devices for skin rejuvenation, hair removal, and anti-aging treatments has fueled market expansion. Additionally, the Covid-19 pandemic accelerated the shift toward at-home beauty solutions, further increasing demand. Moreover, advancements in device safety, efficacy, and connectivity with mobile applications enhance user experience, contributing to the rapid adoption of home-use aesthetic devices
During the forecast period, the North America region is expected to hold the largest market share, attributed to high consumer spending on aesthetic procedures and a well-established healthcare infrastructure. The growing acceptance of minimally invasive and non-invasive treatments, along with the presence of key market players, further strengthens the region's dominance. Additionally, technological advancements and frequent product launches contribute to market expansion. Moreover, increasing awareness and social media influence encourage a higher adoption rate of medical aesthetic devices, reinforcing North America's leadership position in the industry.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rising disposable incomes, increasing beauty consciousness, and growing medical tourism. Countries such as China, India, and South Korea are witnessing significant growth due to an expanding middle-class population and increasing demand for aesthetic treatments. Additionally, advancements in aesthetic technologies and affordability of treatments attract a larger consumer base. Moreover, the presence of a skilled workforce and supportive government policies further accelerate the adoption of medical aesthetic devices in the region.
Key players in the market
Some of the key players in Medical Aesthetic Devices Market include AbbVie Inc., Alma Lasers, Bausch Health Companies Inc., Cynosure, Johnson & Johnson, Cutera Inc., El.En. S.p.A., Lumenis Ltd., Sciton Inc., Candela Corporation, Venus Concept, Merz Pharma, Galderma S.A., Hologic Inc., Boston Scientific Corporation, Stryker Corp, Syneron Medical Ltd. and InMode Ltd.
In February 2025, Lumenis Be. Ltd. announced the launch of OptiLIFT, a new, proprietary Dynamic Muscle Stimulation technology (DMSt) for toning facial muscles to address lower lid laxity and impaired blinking without the need for surgery. OptiLIFT is also the inventor of OptiLIGHT, an intense pulsed light (IPL) device granted authorization by the FDA for dry eye management.
In April 2024, Sciton Inc., a pioneer in medical and aesthetic laser and light source technologies, proudly unveiled BBL (R) HEROic(TM) this weekend at the inaugural Skin CEO event in Austin, TX. This latest addition to the award-winning BBL product line represents a significant leap forward, incorporating Intelligent Control(TM) (IC(TM)), and the unique Skin Positioning System(TM) (SPS(TM)) for unmatched patient outcomes.
In March 2024, AbbVie and Allergan Aesthetics, an AbbVie company announced they will present 29 abstracts, including three late-breaking presentations, during the 2024 American Academy of Dermatology (AAD) Annual Meeting, March 8-12, in San Diego, California. The presented data across AbbVie and Allergan Aesthetics' extensive portfolios reinforce the companies' ongoing commitment to developing transformative medical dermatology and aesthetic treatments to advance and redefine the standard of care for patients.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.